Speakers at Gene Drives: Technologies, applications & biosafety challenges

Gene Drives: Technologies, applications & biosafety challenges

About the speakers

  1. Fred Wassenaar

    Fred Wassenaar

    Working address: 
    P.O. Box 1   
    3720 BA Bilthoven   
    The Netherlands

    Tel: +31 6 4686 0957 

    Email: fred.wassenaar@rivm.nl 

    Academic Education and Degrees 

    1980 BSc Van Leeuwenhoek Institute Delft (Rotterdam University of Applied Sciences), The Netherlands  

     Experience and courses:  

    • Biosafety Officer and Senior Biosafety Advisor,
    • Risk assessment of Contained Use of GMOs (Directive 2009/41/EC), accreditation of Biological Safety Professionals for GMOBiosafety education and training (courses, workshops),
    • human genetics (start DNA diagnostics in the Netherlands),   

    • enzyme purification (from cyanobacteria) 

    • immunology  (TCR) 

    • virology (parvovirus B19, baculovirus, HCV, arteriviruses, coronaviruses),  

    • teacher (practical courses on cell culture, virologygmo’s, risk assessment),  

    • occupational health, biosafety and biosecurity (risk assessment and legislation) 

    at Leiden University (with an intermezzo for two years at Promega), Leiden University Medical Center, and  the Dutch National Institute for Public Health and the Environment. 

  2. Patrick Rüdelsheim

    Patrick Rüdelsheim

    Trained as a biologist, Patrick Rüdelsheim started his career in a Dutch seed company. He then joined Plant Genetic Systems N.V., Ghent, Belgium. After being in charge of Product Development and Registration, he was appointed Director Regulatory Affairs and Member of the Board. 

    Following the acquisition of PGS, he became Global Head of Biotechnology Regulatory Affairs for the AgrEvo group and remained in this function during the subsequent creation of Aventis S.A. and the acquisition by Bayer. In this function, he ensured the scientific argumentation for Product Safety and Quality as well as the compliance with all regulatory acquirements related to genetic engineering.

    In 2003, he founded and became General Manager of Perseus BV, a service company focused on bio-safety and related regulatory requirements. Mid 2015, he was co-founder and served as Senior Regulatory Advisor for ABS-int, a multi-disciplinary initiative dedicated to Access and Benefit Sharing requirements for genetic resources. Since 2023, Perseus and ABS-int operate together as 3Bio, in which he acts as Director and Chief Regulatory Officer. In this capacity he offers his extensive and global experience in every aspect of biosafety and biotechnology regulation to a range of users and developers. He lectures on biosafety and regulations at the University of Ghent and the University of Antwerp.


Sorry, the registration period is over.


Ticket type Price
EBSA member € 100.00